nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM1—autonomic nervous system—type 1 diabetes mellitus	0.0174	0.0905	CbGeAlD
Phenoxybenzamine—CALM2—peripheral nervous system—type 1 diabetes mellitus	0.0126	0.0656	CbGeAlD
Phenoxybenzamine—CALM1—peripheral nervous system—type 1 diabetes mellitus	0.0126	0.0653	CbGeAlD
Phenoxybenzamine—CALM2—nerve—type 1 diabetes mellitus	0.00985	0.0511	CbGeAlD
Phenoxybenzamine—CALM1—nerve—type 1 diabetes mellitus	0.0098	0.0509	CbGeAlD
Phenoxybenzamine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00901	0.0468	CbGeAlD
Phenoxybenzamine—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.0067	0.0348	CbGeAlD
Phenoxybenzamine—CALM3—islet of Langerhans—type 1 diabetes mellitus	0.00608	0.0315	CbGeAlD
Phenoxybenzamine—SLC22A2—kidney—type 1 diabetes mellitus	0.00589	0.0306	CbGeAlD
Phenoxybenzamine—ADRA1B—kidney—type 1 diabetes mellitus	0.00564	0.0293	CbGeAlD
Phenoxybenzamine—CALM3—retina—type 1 diabetes mellitus	0.00519	0.027	CbGeAlD
Phenoxybenzamine—CALM3—nephron tubule—type 1 diabetes mellitus	0.00489	0.0254	CbGeAlD
Phenoxybenzamine—CALM2—islet of Langerhans—type 1 diabetes mellitus	0.00477	0.0248	CbGeAlD
Phenoxybenzamine—CALM1—islet of Langerhans—type 1 diabetes mellitus	0.00475	0.0247	CbGeAlD
Phenoxybenzamine—CALM3—pancreas—type 1 diabetes mellitus	0.00427	0.0222	CbGeAlD
Phenoxybenzamine—SLC22A1—kidney—type 1 diabetes mellitus	0.00416	0.0216	CbGeAlD
Phenoxybenzamine—CALM2—retina—type 1 diabetes mellitus	0.00408	0.0212	CbGeAlD
Phenoxybenzamine—CALM1—retina—type 1 diabetes mellitus	0.00406	0.0211	CbGeAlD
Phenoxybenzamine—SLC22A3—kidney—type 1 diabetes mellitus	0.00397	0.0206	CbGeAlD
Phenoxybenzamine—CALM2—nephron tubule—type 1 diabetes mellitus	0.00384	0.0199	CbGeAlD
Phenoxybenzamine—CALM1—nephron tubule—type 1 diabetes mellitus	0.00382	0.0199	CbGeAlD
Phenoxybenzamine—Benzphetamine—SLC18A2—type 1 diabetes mellitus	0.00373	0.3	CrCbGaD
Phenoxybenzamine—CALM2—cardiovascular system—type 1 diabetes mellitus	0.00345	0.0179	CbGeAlD
Phenoxybenzamine—CALM1—cardiovascular system—type 1 diabetes mellitus	0.00343	0.0178	CbGeAlD
Phenoxybenzamine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.00343	0.0178	CbGeAlD
Phenoxybenzamine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.0034	0.0177	CbGeAlD
Phenoxybenzamine—CALM2—kidney—type 1 diabetes mellitus	0.00338	0.0175	CbGeAlD
Phenoxybenzamine—CALM1—kidney—type 1 diabetes mellitus	0.00336	0.0174	CbGeAlD
Phenoxybenzamine—CALM2—pancreas—type 1 diabetes mellitus	0.00335	0.0174	CbGeAlD
Phenoxybenzamine—CALM1—pancreas—type 1 diabetes mellitus	0.00334	0.0173	CbGeAlD
Phenoxybenzamine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00324	0.0168	CbGeAlD
Phenoxybenzamine—ADRA2C—kidney—type 1 diabetes mellitus	0.00302	0.0157	CbGeAlD
Phenoxybenzamine—ADRA2C—pancreas—type 1 diabetes mellitus	0.003	0.0156	CbGeAlD
Phenoxybenzamine—CALM2—lymphoid tissue—type 1 diabetes mellitus	0.0029	0.0151	CbGeAlD
Phenoxybenzamine—CALM1—lymphoid tissue—type 1 diabetes mellitus	0.00289	0.015	CbGeAlD
Phenoxybenzamine—Ethopropazine—CHRM2—type 1 diabetes mellitus	0.00273	0.22	CrCbGaD
Phenoxybenzamine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00272	0.0141	CbGeAlD
Phenoxybenzamine—ADRA2A—pancreas—type 1 diabetes mellitus	0.00239	0.0124	CbGeAlD
Phenoxybenzamine—Propafenone—ADRB1—type 1 diabetes mellitus	0.00208	0.168	CrCbGaD
Phenoxybenzamine—CYP3A4—kidney—type 1 diabetes mellitus	0.0019	0.00984	CbGeAlD
Phenoxybenzamine—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.00142	0.114	CrCbGaD
Phenoxybenzamine—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.00135	0.108	CrCbGaD
Phenoxybenzamine—Fenoprofen—ALB—type 1 diabetes mellitus	0.00112	0.09	CrCbGaD
Phenoxybenzamine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	4.51e-05	5.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.5e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.5e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	4.49e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.48e-05	5.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.48e-05	5.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	4.47e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.44e-05	5.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD80—type 1 diabetes mellitus	4.42e-05	5.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD80—type 1 diabetes mellitus	4.42e-05	5.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS2—type 1 diabetes mellitus	4.35e-05	5.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.32e-05	5.44e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	4.32e-05	5.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.31e-05	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.3e-05	5.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.27e-05	5.37e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	4.25e-05	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.24e-05	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.24e-05	5.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.22e-05	5.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD80—type 1 diabetes mellitus	4.22e-05	5.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EGFR—type 1 diabetes mellitus	4.22e-05	5.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.22e-05	5.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.21e-05	5.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS2—type 1 diabetes mellitus	4.21e-05	5.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS2—type 1 diabetes mellitus	4.21e-05	5.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.21e-05	5.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.18e-05	5.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.15e-05	5.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	4.13e-05	5.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.09e-05	5.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.09e-05	5.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD80—type 1 diabetes mellitus	4.08e-05	5.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD80—type 1 diabetes mellitus	4.08e-05	5.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EGFR—type 1 diabetes mellitus	4.08e-05	5.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EGFR—type 1 diabetes mellitus	4.08e-05	5.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.07e-05	5.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.07e-05	5.12e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	4.06e-05	5.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CD86—type 1 diabetes mellitus	4.05e-05	5.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—EGFR—type 1 diabetes mellitus	4.05e-05	5.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	4.03e-05	5.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4e-05	5.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.99e-05	5.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—INS—type 1 diabetes mellitus	3.99e-05	5.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.99e-05	5.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	3.98e-05	5.01e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	3.96e-05	4.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	3.95e-05	4.97e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.94e-05	4.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.93e-05	4.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CD86—type 1 diabetes mellitus	3.92e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CD86—type 1 diabetes mellitus	3.92e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.92e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—EGFR—type 1 diabetes mellitus	3.92e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	3.92e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.9e-05	4.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.88e-05	4.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.88e-05	4.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—TYK2—type 1 diabetes mellitus	3.86e-05	4.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—INS—type 1 diabetes mellitus	3.86e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—INS—type 1 diabetes mellitus	3.86e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.85e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.85e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.85e-05	4.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.83e-05	4.82e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	3.79e-05	4.77e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	3.79e-05	4.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.77e-05	4.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—TYK2—type 1 diabetes mellitus	3.73e-05	4.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—TYK2—type 1 diabetes mellitus	3.73e-05	4.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.72e-05	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.72e-05	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	3.71e-05	4.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	3.66e-05	4.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.65e-05	4.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.65e-05	4.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.63e-05	4.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNG—type 1 diabetes mellitus	3.61e-05	4.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.6e-05	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.59e-05	4.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.59e-05	4.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.57e-05	4.49e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.57e-05	4.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TYK2—type 1 diabetes mellitus	3.56e-05	4.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.56e-05	4.48e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.55e-05	4.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.54e-05	4.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.54e-05	4.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.53e-05	4.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.53e-05	4.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.51e-05	4.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS3—type 1 diabetes mellitus	3.5e-05	4.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNG—type 1 diabetes mellitus	3.5e-05	4.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNG—type 1 diabetes mellitus	3.5e-05	4.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.49e-05	4.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD4—type 1 diabetes mellitus	3.49e-05	4.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.49e-05	4.39e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.48e-05	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.48e-05	4.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.48e-05	4.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TYK2—type 1 diabetes mellitus	3.45e-05	4.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TYK2—type 1 diabetes mellitus	3.45e-05	4.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.43e-05	4.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.43e-05	4.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.4e-05	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.4e-05	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS3—type 1 diabetes mellitus	3.38e-05	4.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS3—type 1 diabetes mellitus	3.38e-05	4.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD4—type 1 diabetes mellitus	3.38e-05	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD4—type 1 diabetes mellitus	3.38e-05	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.37e-05	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	3.36e-05	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—INS—type 1 diabetes mellitus	3.34e-05	4.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.33e-05	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	3.32e-05	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.31e-05	4.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.31e-05	4.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.3e-05	4.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.29e-05	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.25e-05	4.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—type 1 diabetes mellitus	3.24e-05	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.24e-05	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—INS—type 1 diabetes mellitus	3.23e-05	4.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—INS—type 1 diabetes mellitus	3.23e-05	4.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—type 1 diabetes mellitus	3.22e-05	4.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD4—type 1 diabetes mellitus	3.22e-05	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL2—type 1 diabetes mellitus	3.21e-05	4.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	3.21e-05	4.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.19e-05	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.17e-05	3.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—type 1 diabetes mellitus	3.14e-05	3.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—type 1 diabetes mellitus	3.14e-05	3.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—type 1 diabetes mellitus	3.12e-05	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—type 1 diabetes mellitus	3.12e-05	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD4—type 1 diabetes mellitus	3.12e-05	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD4—type 1 diabetes mellitus	3.12e-05	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL2—type 1 diabetes mellitus	3.11e-05	3.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL2—type 1 diabetes mellitus	3.11e-05	3.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—type 1 diabetes mellitus	3.06e-05	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	3.06e-05	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3e-05	3.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	3e-05	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.98e-05	3.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.97e-05	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—type 1 diabetes mellitus	2.96e-05	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—type 1 diabetes mellitus	2.96e-05	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.96e-05	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.96e-05	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.96e-05	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.95e-05	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.95e-05	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.94e-05	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NOS3—type 1 diabetes mellitus	2.93e-05	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.89e-05	3.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.86e-05	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CD80—type 1 diabetes mellitus	2.86e-05	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NOS3—type 1 diabetes mellitus	2.83e-05	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NOS3—type 1 diabetes mellitus	2.83e-05	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.81e-05	3.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.8e-05	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.8e-05	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—INS—type 1 diabetes mellitus	2.79e-05	3.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.79e-05	3.51e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2.78e-05	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.76e-05	3.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.76e-05	3.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.74e-05	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.73e-05	3.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—STAT3—type 1 diabetes mellitus	2.7e-05	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—INS—type 1 diabetes mellitus	2.7e-05	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—INS—type 1 diabetes mellitus	2.7e-05	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.7e-05	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.69e-05	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.68e-05	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—STAT3—type 1 diabetes mellitus	2.61e-05	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—STAT3—type 1 diabetes mellitus	2.61e-05	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.61e-05	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.61e-05	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.6e-05	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.6e-05	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.54e-05	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.52e-05	3.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.5e-05	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—STAT3—type 1 diabetes mellitus	2.5e-05	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.49e-05	3.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EGFR—type 1 diabetes mellitus	2.46e-05	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.45e-05	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.45e-05	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.45e-05	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.44e-05	3.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.41e-05	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.41e-05	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—STAT3—type 1 diabetes mellitus	2.41e-05	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—STAT3—type 1 diabetes mellitus	2.41e-05	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EGFR—type 1 diabetes mellitus	2.38e-05	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EGFR—type 1 diabetes mellitus	2.38e-05	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.37e-05	2.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.37e-05	2.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.36e-05	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.35e-05	2.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.32e-05	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.29e-05	2.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.28e-05	2.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.28e-05	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—type 1 diabetes mellitus	2.27e-05	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.26e-05	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.26e-05	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—type 1 diabetes mellitus	2.19e-05	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—type 1 diabetes mellitus	2.19e-05	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.14e-05	2.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.11e-05	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.08e-05	2.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—type 1 diabetes mellitus	2.08e-05	2.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.07e-05	2.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.06e-05	2.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.01e-05	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.01e-05	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.01e-05	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.01e-05	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2e-05	2.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2e-05	2.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	1.95e-05	2.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.91e-05	2.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—type 1 diabetes mellitus	1.89e-05	2.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.87e-05	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—type 1 diabetes mellitus	1.83e-05	2.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—type 1 diabetes mellitus	1.83e-05	2.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.76e-05	2.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.75e-05	2.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—type 1 diabetes mellitus	1.74e-05	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.74e-05	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.74e-05	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.69e-05	2.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.69e-05	2.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—type 1 diabetes mellitus	1.69e-05	2.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—type 1 diabetes mellitus	1.69e-05	2.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.65e-05	2.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.62e-05	2.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.59e-05	2e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.56e-05	1.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.54e-05	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.54e-05	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.44e-05	1.81e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.43e-05	1.8e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.37e-05	1.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.34e-05	1.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.22e-05	1.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.18e-05	1.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.18e-05	1.49e-05	CbGpPWpGaD
